181 related articles for article (PubMed ID: 31275973)
21. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
[TBL] [Abstract][Full Text] [Related]
22. Molecular and histopathological characterization of seminoma patients with highly elevated human chorionic gonadotropin levels in the serum.
Seidel C; Paulsen FO; Nestler T; Cathomas R; Hentrich M; Paffenholz P; Bokemeyer C; Heidenreich A; Nettersheim D; Bremmer F
Virchows Arch; 2023 Dec; ():. PubMed ID: 38097681
[TBL] [Abstract][Full Text] [Related]
23. Radiomics and Clinicopathological Characteristics for Predicting Lymph Node Metastasis in Testicular Cancer.
Lisson CS; Manoj S; Wolf D; Lisson CG; Schmidt SA; Beer M; Thaiss W; Bolenz C; Zengerling F; Goetz M
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067334
[TBL] [Abstract][Full Text] [Related]
24. Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
Belge G; Dumlupinar C; Nestler T; Klemke M; Törzsök P; Trenti E; Pichler R; Loidl W; Che Y; Hiester A; Matthies C; Pichler M; Paffenholz P; Kluth L; Wenzel M; Sommer J; Heinzelbecker J; Schriefer P; Winter A; Zengerling F; Kramer MW; Lengert M; Frey J; Heidenreich A; Wülfing C; Radtke A; Dieckmann KP
Clin Cancer Res; 2024 Jan; 30(2):404-412. PubMed ID: 37967143
[TBL] [Abstract][Full Text] [Related]
25. A decade in focus: mixed germ cell tumors with choriocarcinoma components.
Al-Khayal A; Noureldin Y; Alghafees M; Shafqat A; Sabbah BN; Elhossiny AH; Bakir M; Omar MA; Arabi TZ; Abdul Rab S; Alsaikhan B; Aldhalaan R; Alquirnas M; Alrabeeah K
Ann Med Surg (Lond); 2023 Nov; 85(11):5355-5358. PubMed ID: 37915675
[TBL] [Abstract][Full Text] [Related]
26. CSNK1G2-AS1 promotes metastasis, colony formation and serves as a biomarker in testicular germ cell tumor cells.
Li R; Zhou Q; Liu G; Zhu F; Liu Z; Bo H; Fan L
J Cancer; 2023; 14(15):2771-2783. PubMed ID: 37781070
[No Abstract] [Full Text] [Related]
27. Subsets of preoperative sex hormones in testicular germ cell cancer: a retrospective multicenter study.
Törzsök P; Oswald D; Dieckmann KP; Angerer M; Scherer LC; Tymoszuk P; Kunz Y; Pinggera GM; Lusuardi L; Horninger W; Pichler R
Sci Rep; 2023 Sep; 13(1):14604. PubMed ID: 37669975
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic Factors and ncRNAs in Testicular Cancer.
Nuñez-Corona D; Contreras-Sanzón E; Puente-Rivera J; Arreola R; Camacho-Nuez M; Cruz Santiago J; Estrella-Parra EA; Torres-Romero JC; López-Camarillo C; Alvarez-Sánchez ME
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569569
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-371a-3p-The Novel Serum Biomarker in Testicular Germ Cell Tumors.
Nestler T; Schoch J; Belge G; Dieckmann KP
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568759
[TBL] [Abstract][Full Text] [Related]
30. Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
Majewski M; Paffenholz P; Ruf C; Che Y; Seidel C; Heinzelbecker J; Schmelz HU; Matthies C; Albers P; Bokemeyer C; Heidenreich A; Pichler M; Nestler T;
Cancer Med; 2023 Aug; 12(16):16829-16836. PubMed ID: 37392170
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Significance of Systemic Inflammation Markers in Testicular and Penile Cancer: A Narrative Review of Current Literature.
Janicic A; Petrovic M; Zekovic M; Vasilic N; Coric V; Milojevic B; Zivkovic M; Bumbasirevic U
Life (Basel); 2023 Feb; 13(3):. PubMed ID: 36983756
[TBL] [Abstract][Full Text] [Related]
32. Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age-a statistical analysis.
Dieckmann KP; Dumlupinar C; Grobelny F; Utschig J; Klemke M; Ahmed Saad EM; Wülfing C; Pichlmeier U; Isbarn H; Belge G
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7079-7090. PubMed ID: 36869885
[TBL] [Abstract][Full Text] [Related]
33. Testis and epididymis-unusual sites of metastatic gastric cancer: A case report and review of the literature.
Ji JJ; Guan FJ; Yao Y; Sun LJ; Zhang GM
World J Clin Cases; 2022 Nov; 10(32):11974-11979. PubMed ID: 36405257
[TBL] [Abstract][Full Text] [Related]
34. Testicular Neoplasms: Primary Tumour Size Is Closely Interrelated with Histology, Clinical Staging, and Tumour Marker Expression Rates-A Comprehensive Statistical Analysis.
Dieckmann KP; Isbarn H; Grobelny F; Dumlupinar C; Utschig J; Wülfing C; Pichlmeier U; Belge G
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358866
[TBL] [Abstract][Full Text] [Related]
35. [Testicular tumours from a clinical point of view : What urologists and oncologists need to know from the pathologist about testicular cancer].
Oing C; Fankhauser CD
Pathologie (Heidelb); 2022 Nov; 43(6):434-440. PubMed ID: 36156132
[TBL] [Abstract][Full Text] [Related]
36. Biomarkers of disease recurrence in stage I testicular germ cell tumours.
Lesko P; Chovanec M; Mego M
Nat Rev Urol; 2022 Nov; 19(11):637-658. PubMed ID: 36028719
[TBL] [Abstract][Full Text] [Related]
37. Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting.
Ye F; Feldman DR; Valentino A; So R; Bromberg M; Khan S; Funt SA; Sheinfeld J; Solit DB; Pessin MS; Peerschke EI
J Mol Diagn; 2022 Aug; 24(8):867-877. PubMed ID: 35934321
[TBL] [Abstract][Full Text] [Related]
38. Progesterone limits the tumor-promoting effects of the beta-subunit of human chorionic gonadotropin via non-nuclear receptors.
Sarkar M; Sharma H; Singh P; Ranu R; Sharma RD; Agrawal U; Pal R
iScience; 2022 Jul; 25(7):104527. PubMed ID: 35754725
[TBL] [Abstract][Full Text] [Related]
39. The utility of cfDNA in TGCT patient management: a systematic review.
Krasic J; Skara L; Bojanac AK; Ulamec M; Jezek D; Kulis T; Sincic N
Ther Adv Med Oncol; 2022; 14():17588359221090365. PubMed ID: 35656387
[TBL] [Abstract][Full Text] [Related]
40. [Follow-up of testicular germ cell tumors-historical aspects and current recommendations].
Dieckmann KP; Ruf CG; Gübitz R; Wülfing C; Zengerling F
Urologe A; 2022 May; 61(5):484-494. PubMed ID: 35384479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
